Pharma IQ | 11/08/2010
In this interview Jerold Martin, Sr. V.P., Global Scientific Affairs, Biopharmaceuticals, Pall Life Sciences and Chairman of the Board and Technology Committee at the BPSA, speaks to Andrea Charles from Pharma IQ, about future trends for Single-Use biomanufacturing and the advantages of Single-Use systems for biomanufacturing. Martin also shares his experiences regarding what factors to consider when implementing a Single-Use technology and their environmental impact.
To continue reading this story Click Here
RECOMMENDED
The Trust Equation: Why Transparency Defines the Future Winners in Contract Manufacturing
2025-12-17
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More